Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | BCDIN3D | Q7Z5W3 | 14/20 | 0.67 |
| ▸ | HTR2C | P28335 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13944705 | 0.90 | TP53 (0.64) | TP53MAPTBCDIN3DHTR2C | |
| SCHEMBL13947571 | 0.89 | PDE2A (0.67) | TP53MAPTBCDIN3D | |
| SCHEMBL13947365 | 0.86 | BCDIN3D (0.70) | TP53MAPTBCDIN3DHTR2CHTT | |
| SCHEMBL13944198 | 0.84 | BCDIN3D (0.67) | TP53MAPTBCDIN3DHTR2CHTT | |
| SCHEMBL13947368 | 0.84 | BCDIN3D (0.67) | TP53MAPTBCDIN3DHTR2CHTT | |
| SCHEMBL13947130 | 0.83 | BCDIN3D (0.65) | TP53MAPTBCDIN3DHTR2CHTT | |
| SCHEMBL13944747 | 0.83 | BCDIN3D (0.65) | TP53MAPTBCDIN3DHTR2CHTT | |
| SCHEMBL22805563 | 0.81 | BCDIN3D (1.00) | BCDIN3D | |
| SCHEMBL13946811 | 0.80 | BCDIN3D (0.62) | BCDIN3DHTR2CHTT | |
| SCHEMBL23580247 | 0.78 | BCDIN3D (0.65) | MAPTBCDIN3DHTR2CHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009023978-A1 | PYRAZOLO [3,4 -D] PYRIMIDINE COMPOUNDS AND THEIR USE AS MODULATORS OF PROTEIN KINASE | ONCALIS AG (CH) | 2009-02-26 | — | — | WO | disclosed |